Cytomos is an innovative biotechnology company based at the University of Edinburgh's Easter Bush Campus. Backed by investors, it is leading the development of its groundbreaking AuraCyt™ technology, designed to revolutionize biotechnologies through repurposed microelectronics. The company's purpose-driven approach focuses on enabling cost-effective solutions and economies of scale in bioprocessing and cell and gene therapy. AuraCyt™ is already showing immense potential in accelerating drug discovery, development, and streamlining manufacturing with real-time, single-cell analytics. Cytomos continues to collaborate with major biotech and pharma companies, striving to become the leading partner in real-time cell analysis for the biopharmaceutical industry.